$ACA

Arcosa, Inc.

0
1
0

No SEC Form 4 filings for $ACA in the last 30 days.

See all $ACA insider activity →
Low

Is Arcosa (ACA) Fully Priced As It Reaffirms Its Dividend?

Arcosa (ACA) reaffirmed its quarterly dividend of $0.05 per share, payable in October 2026. The stock has seen a 52.56% total return over the past year, with shares trading near analyst price targets. Analysts expect $2.6 billion in revenue and $248.1 million in earnings by 2029, with a PE ratio of 38.0x. The stock trades at 32.4x earnings, higher than peers, raising valuation concerns.

Arcosa Stockholders Approve Acquisition by CRH

Arcosa (ACA) stockholders approved the acquisition by CRH (CRH) for $150 per share. The deal, expected to close in Q1 2027, is subject to regulatory approvals. Arcosa is an infrastructure products and solutions provider with segments in Construction Products and Engineered Structures.

ACA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ACA (Arcosa, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent ACA coverage spans mergers & acquisitions, corporate actions and financial news.

What's driving ACA

AlphAI scores every news story that mentions ACA with an AI model for sentiment and relevance, and aggregates insider trades from Arcosa, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ACA

Score
$ACALow

Is Arcosa (ACA) Fully Priced As It Reaffirms Its Dividend?

Arcosa (ACA) reaffirmed its quarterly dividend of $0.05 per share, payable in October 2026. The stock has seen a 52.56% total return over the past year, with shares trading near analyst price targets. Analysts expect $2.6 billion in revenue and $248.1 million in earnings by 2029, with a PE ratio of 38.0x. The stock trades at 32.4x earnings, higher than peers, raising valuation concerns.

$ACAHighAI 8/10

Arcosa Stockholders Approve Acquisition by CRH

Arcosa (ACA) stockholders approved the acquisition by CRH (CRH) for $150 per share. The deal, expected to close in Q1 2027, is subject to regulatory approvals. Arcosa is an infrastructure products and solutions provider with segments in Construction Products and Engineered Structures.

$ACALowAI 8/10

ACA Looks 46.2% Overvalued on GF Value™ Amid CRH Acquisition App

Arcosa Inc (ACA) shareholders approved its acquisition by CRH for $150 per share, pending regulatory approval. ACA's stock is 46.2% overvalued per GF Value™ at $145.45 vs. intrinsic value of $99.52. CRH's acquisition is expected to close in Q1 2027. ACA's GF Score™ is 76/100, with strong momentum and profitability but weak valuation. 9 gurus hold ACA, with 8 adding positions.

Arcosa, Inc. (ACA): Submission of Matters to a Vote of Security Holders

Arcosa, Inc. (ACA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 4, 2026, Arcosa, Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”) at which the Company’s stockholders considered certain proposals related to the Agreement and Plan of M

Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?

CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.

Related tickers